A systematic review of population based epidemiological studies in Myasthenia Gravis
<p>Abstract</p> <p>Background</p> <p>The aim was to collate all myasthenia gravis (MG) epidemiological studies including AChR MG and MuSK MG specific studies. To synthesize data on incidence rate (IR), prevalence rate (PR) and mortality rate (MR) of the condition and in...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-06-01
|
| Series: | BMC Neurology |
| Online Access: | http://www.biomedcentral.com/1471-2377/10/46 |
| _version_ | 1818565056070156288 |
|---|---|
| author | McCarron Peter O Cardwell Chris R Carr Aisling S McConville John |
| author_facet | McCarron Peter O Cardwell Chris R Carr Aisling S McConville John |
| author_sort | McCarron Peter O |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>The aim was to collate all myasthenia gravis (MG) epidemiological studies including AChR MG and MuSK MG specific studies. To synthesize data on incidence rate (IR), prevalence rate (PR) and mortality rate (MR) of the condition and investigate the influence of environmental and technical factors on any trends or variation observed.</p> <p>Methods</p> <p>Studies were identified using multiple sources and meta-analysis performed to calculate pooled estimates for IR, PR and MR.</p> <p>Results</p> <p>55 studies performed between 1950 and 2007 were included, representing 1.7 billion population-years. For All MG estimated pooled IR (eIR): 5.3 per million person-years (C.I.:4.4, 6.1), range: 1.7 to 21.3; estimated pooled PR: 77.7 per million persons (C.I.:64.0, 94.3), range 15 to 179; MR range 0.1 to 0.9 per millions person-years. AChR MG eIR: 7.3 (C.I.:5.5, 7.8), range: 4.3 to 18.0; MuSK MG IR range: 0.1 to 0.32. However marked variation persisted between populations studied with similar methodology and in similar areas.</p> <p>Conclusions</p> <p>We report marked variation in observed frequencies of MG. We show evidence of increasing frequency of MG with year of study and improved study quality. This probably reflects improved case ascertainment. But other factors must also influence disease onset resulting in the observed variation in IR across geographically and genetically similar populations.</p> |
| first_indexed | 2024-12-14T01:36:27Z |
| format | Article |
| id | doaj.art-7da5e6fb4d044b81ac2fde4619d8f170 |
| institution | Directory Open Access Journal |
| issn | 1471-2377 |
| language | English |
| last_indexed | 2024-12-14T01:36:27Z |
| publishDate | 2010-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Neurology |
| spelling | doaj.art-7da5e6fb4d044b81ac2fde4619d8f1702022-12-21T23:21:52ZengBMCBMC Neurology1471-23772010-06-011014610.1186/1471-2377-10-46A systematic review of population based epidemiological studies in Myasthenia GravisMcCarron Peter OCardwell Chris RCarr Aisling SMcConville John<p>Abstract</p> <p>Background</p> <p>The aim was to collate all myasthenia gravis (MG) epidemiological studies including AChR MG and MuSK MG specific studies. To synthesize data on incidence rate (IR), prevalence rate (PR) and mortality rate (MR) of the condition and investigate the influence of environmental and technical factors on any trends or variation observed.</p> <p>Methods</p> <p>Studies were identified using multiple sources and meta-analysis performed to calculate pooled estimates for IR, PR and MR.</p> <p>Results</p> <p>55 studies performed between 1950 and 2007 were included, representing 1.7 billion population-years. For All MG estimated pooled IR (eIR): 5.3 per million person-years (C.I.:4.4, 6.1), range: 1.7 to 21.3; estimated pooled PR: 77.7 per million persons (C.I.:64.0, 94.3), range 15 to 179; MR range 0.1 to 0.9 per millions person-years. AChR MG eIR: 7.3 (C.I.:5.5, 7.8), range: 4.3 to 18.0; MuSK MG IR range: 0.1 to 0.32. However marked variation persisted between populations studied with similar methodology and in similar areas.</p> <p>Conclusions</p> <p>We report marked variation in observed frequencies of MG. We show evidence of increasing frequency of MG with year of study and improved study quality. This probably reflects improved case ascertainment. But other factors must also influence disease onset resulting in the observed variation in IR across geographically and genetically similar populations.</p>http://www.biomedcentral.com/1471-2377/10/46 |
| spellingShingle | McCarron Peter O Cardwell Chris R Carr Aisling S McConville John A systematic review of population based epidemiological studies in Myasthenia Gravis BMC Neurology |
| title | A systematic review of population based epidemiological studies in Myasthenia Gravis |
| title_full | A systematic review of population based epidemiological studies in Myasthenia Gravis |
| title_fullStr | A systematic review of population based epidemiological studies in Myasthenia Gravis |
| title_full_unstemmed | A systematic review of population based epidemiological studies in Myasthenia Gravis |
| title_short | A systematic review of population based epidemiological studies in Myasthenia Gravis |
| title_sort | systematic review of population based epidemiological studies in myasthenia gravis |
| url | http://www.biomedcentral.com/1471-2377/10/46 |
| work_keys_str_mv | AT mccarronpetero asystematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT cardwellchrisr asystematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT carraislings asystematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT mcconvillejohn asystematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT mccarronpetero systematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT cardwellchrisr systematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT carraislings systematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis AT mcconvillejohn systematicreviewofpopulationbasedepidemiologicalstudiesinmyastheniagravis |